Tech Company Financing Transactions
Lumos Pharma Funding Round
Lumos Pharma, based in Austin, secured $14 million from New Enterprise Associates and Sante Ventures.
Transaction Overview
Company Name
Announced On
2/6/2014
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
New Enterprise Associates (Lead Investor) (Ed Mathers)
Sante Ventures (Lead Investor) (Kevin Lalande)
Proceeds Purpose
Lumos Pharma will use the financing to support the preclinical and clinical development of its lead compound, LUM-001.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4200 Marathon Blvd. 200
Austin, TX 78756
USA
Austin, TX 78756
USA
Phone
Website
Email Address
Overview
Lumos Pharma, based in Austin, Texas, is an early stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Hawkins
Chief Financial Officer
Carl Langren
Chief Medical Officer
Eugene Kennedy
Chief Operating Officer
John McKew
VP - Bus. Development
Aaron Schuchart
VP - Finance
Lori Lawley
VP - General Counsel
Brad Powers
Browse more venture capital transactions:
Prev: 2/6/2014: PayNearMe venture capital transaction
Next: 2/6/2014: BizSlate venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs